Indinavir monohydrate is a potent protease inhibitor belonging to the class of antiretroviral agents, historically utilized to treat HIV/AIDS by inhibiting the replication of the virus. While its clinical… Read more
Indinavir monohydrate is a potent protease inhibitor belonging to the class of antiretroviral agents, historically utilized to treat HIV/AIDS by inhibiting the replication of the virus. While its clinical application is now limited due to potential adverse effects such as nephrolithiasis and pancreatitis, maintaining robust analytical protocols for the drug remains essential. This category includes high-quality reference standards for indinavir monohydrate, alongside its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories rely on these specialized materials to perform critical impurity profiling, method validation, and accurate quality control of the active pharmaceutical ingredient. By providing these specific analytical tools, researchers can effectively identify and quantify related substances, ensuring compliance with strict regulatory standards and supporting the ongoing study of protease inhibitor pharmacology and drug stability.